Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Withanoside-IV is a phytosterol glycoside that has been found in W. somnifera and has neuroprotective activity.1,2,3 It reduces parietal cortex neuronal atrophy and prevents spatial memory deficits in the water maze test induced by amyloid-β (25-35) (Aβ (25-35)) in a mouse model of Alzheimer's disease when administered at a dose of 10 µmol/kg per day.2 Withanoside-IV (10 µmol/kg per day) increases spinal cord axonal growth and density and myelin levels in a mouse model of surgery-induced spinal cord injury (SCI).3
WARNING This product is not for human or veterinary use.
1. Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. Chem. Pharm. Bull. (Tokyo) 50(6), 760-765 (2002).
2. Withanoside IV and its active metabolite, sominone, attenuate Aβ(25-
3. Withanoside IV improves hindlimb function by facilitating axonal growth and increase in peripheral nervous system myelin level after spinal cord injury. Neurosci. Res. 58(2), 176-182 (2007).